RxDoctor Payments Data

Mark Hasenauer, MD

Adult Reconstructive Orthopaedic Surgery · Baltimore, MDNPI 1710372271

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (57.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Smith+Nephew at 57.7% of the total. 2025 is the largest year on record at $11,472, more than ten times the $22 reported in 2019.

$34,920in general payments, 2019–2025

Across 62 payments — averaging $563.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$20K
  • Depuy Synthes Products, Inc.$6K
  • Medical Device Business Services, Inc.$5K
  • Zimmer Biomet$3K
  • Johnson & Johnson$657
  • Stryker$301
  • plus $44 from 2 others

What the payments were for

  • Consulting fees$10,04529%
  • Travel & lodging$2,0066%
  • Food & beverage$2,8708%
  • Education$20,00057%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,920 in reported general payments places this provider in the 70th percentile of 33 adult reconstructive orthopaedic surgery providers in Maryland.

See all adult reconstructive orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$419,219
Medicare patients
552
Services billed
2,527

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib22$560
Methylprednisolone45$305
Cephalexin17$203
Oxycodone Hcl29$104
Meloxicam42$96
Tramadol Hcl26$89
Amoxicillin16$11

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →